President Trump’s Drug Pricing Plan: Is This Pharma’s Last Chance at Self-Regulation?
President Trump has released his long-awaited plan to address prescription drug prices, the mysterious contents of which have been causing heartburn for manufacturers, pharmacy benefit managers (PBMs), health plans, and other stakeholders for several weeks. The consensus seemed to be that manufacturers and PBMs were likely to have large targets on their backs. On the […]
Read More